1.005 USD
+0.09 (+9.33%)
We assign a fundamental rating of 2 out of 10 to FEMY. FEMY was compared to 188 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of FEMY have multiple concerns. While showing a medium growth rate, FEMY is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
FEMY had negative earnings in the past year.
FEMY had a negative operating cash flow in the past year.
In the past 5 years FEMY always reported negative net income.
In the past 5 years FEMY always reported negative operating cash flow.
1.2 Ratios
FEMY's Return On Assets of -152.51% is on the low side compared to the rest of the industry. FEMY is outperformed by 87.77% of its industry peers.
Looking at the Return On Equity, with a value of -1394.22%, FEMY is doing worse than 87.77% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -152.51% | ||
| ROE | -1394.22% | ||
| ROIC | N/A |
ROA(3y)-89.97%
ROA(5y)-77.42%
ROE(3y)-322.97%
ROE(5y)-238.66%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 65.09%, FEMY is in the better half of the industry, outperforming 67.55% of the companies in the same industry.
In the last couple of years the Gross Margin of FEMY has declined.
The Profit Margin and Operating Margin are not available for FEMY so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 65.09% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y-2.71%
2. Health
2.1 Basic Checks
FEMY does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, FEMY has more shares outstanding
The number of shares outstanding for FEMY has been increased compared to 5 years ago.
The debt/assets ratio for FEMY is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of -16.43, we must say that FEMY is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of FEMY (-16.43) is worse than 84.04% of its industry peers.
FEMY has a Debt/Equity ratio of 4.03. This is a high value indicating a heavy dependency on external financing.
FEMY has a worse Debt to Equity ratio (4.03) than 85.64% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.03 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -16.43 |
ROIC/WACCN/A
WACC7.95%
2.3 Liquidity
A Current Ratio of 0.89 indicates that FEMY may have some problems paying its short term obligations.
FEMY's Current ratio of 0.89 is on the low side compared to the rest of the industry. FEMY is outperformed by 90.43% of its industry peers.
FEMY has a Quick Ratio of 0.89. This is a bad value and indicates that FEMY is not financially healthy enough and could expect problems in meeting its short term obligations.
FEMY has a worse Quick ratio (0.41) than 93.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.89 | ||
| Quick Ratio | 0.41 |
3. Growth
3.1 Past
FEMY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.35%, which is quite good.
Looking at the last year, FEMY shows a very strong growth in Revenue. The Revenue has grown by 51.97%.
FEMY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.86% yearly.
EPS 1Y (TTM)12.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.33%
Revenue 1Y (TTM)51.97%
Revenue growth 3Y11.35%
Revenue growth 5Y11.86%
Sales Q2Q%31.35%
3.2 Future
FEMY is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.14% yearly.
The Revenue is expected to grow by 109.73% on average over the next years. This is a very strong growth
EPS Next Y29.2%
EPS Next 2Y28.53%
EPS Next 3Y19.91%
EPS Next 5Y15.14%
Revenue Next Year8.11%
Revenue Next 2Y67.18%
Revenue Next 3Y126.15%
Revenue Next 5Y109.73%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
FEMY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year FEMY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as FEMY's earnings are expected to grow with 19.91% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.53%
EPS Next 3Y19.91%
5. Dividend
5.1 Amount
No dividends for FEMY!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:FEMY (11/25/2025, 11:33:08 AM)
1.005
+0.09 (+9.33%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners14.09%
Inst Owner Change-26.09%
Ins Owners11.44%
Ins Owner Change9.52%
Market Cap43.23M
Revenue(TTM)1.63M
Net Income(TTM)-21.02M
Analysts82.22
Price Target5.78 (475.12%)
Short Float %13.82%
Short Ratio0.54
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.19%
Min EPS beat(2)-18.68%
Max EPS beat(2)18.3%
EPS beat(4)1
Avg EPS beat(4)-9.98%
Min EPS beat(4)-21.89%
Max EPS beat(4)18.3%
EPS beat(8)3
Avg EPS beat(8)-5.92%
EPS beat(12)5
Avg EPS beat(12)-4.03%
EPS beat(16)7
Avg EPS beat(16)-0.14%
Revenue beat(2)0
Avg Revenue beat(2)-62.91%
Min Revenue beat(2)-70.71%
Max Revenue beat(2)-55.12%
Revenue beat(4)0
Avg Revenue beat(4)-51.94%
Min Revenue beat(4)-70.71%
Max Revenue beat(4)-16.58%
Revenue beat(8)0
Avg Revenue beat(8)-46.57%
Revenue beat(12)1
Avg Revenue beat(12)-34.57%
Revenue beat(16)3
Avg Revenue beat(16)-25.25%
PT rev (1m)-9.33%
PT rev (3m)-9.33%
EPS NQ rev (1m)-4%
EPS NQ rev (3m)-4%
EPS NY rev (1m)-10.28%
EPS NY rev (3m)0%
Revenue NQ rev (1m)8.75%
Revenue NQ rev (3m)8.75%
Revenue NY rev (1m)-10.77%
Revenue NY rev (3m)-10.77%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 22.91 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 28.68 | ||
| P/tB | 29.77 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.71
EYN/A
EPS(NY)-0.3
Fwd EYN/A
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)-0.46
OCFYN/A
SpS0.04
BVpS0.04
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -152.51% | ||
| ROE | -1394.22% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 65.09% | ||
| FCFM | N/A |
ROA(3y)-89.97%
ROA(5y)-77.42%
ROE(3y)-322.97%
ROE(5y)-238.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y-2.71%
F-Score3
Asset Turnover0.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.03 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 222.91% | ||
| Cap/Sales | 39.29% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.89 | ||
| Quick Ratio | 0.41 | ||
| Altman-Z | -16.43 |
F-Score3
WACC7.95%
ROIC/WACCN/A
Cap/Depr(3y)129.38%
Cap/Depr(5y)89.02%
Cap/Sales(3y)33.12%
Cap/Sales(5y)25.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.33%
EPS Next Y29.2%
EPS Next 2Y28.53%
EPS Next 3Y19.91%
EPS Next 5Y15.14%
Revenue 1Y (TTM)51.97%
Revenue growth 3Y11.35%
Revenue growth 5Y11.86%
Sales Q2Q%31.35%
Revenue Next Year8.11%
Revenue Next 2Y67.18%
Revenue Next 3Y126.15%
Revenue Next 5Y109.73%
EBIT growth 1Y-16.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-82.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-79%
OCF growth 3YN/A
OCF growth 5YN/A
FEMASYS INC / FEMY FAQ
What is the ChartMill fundamental rating of FEMASYS INC (FEMY) stock?
ChartMill assigns a fundamental rating of 2 / 10 to FEMY.
Can you provide the valuation status for FEMASYS INC?
ChartMill assigns a valuation rating of 0 / 10 to FEMASYS INC (FEMY). This can be considered as Overvalued.
Can you provide the profitability details for FEMASYS INC?
FEMASYS INC (FEMY) has a profitability rating of 1 / 10.
How financially healthy is FEMASYS INC?
The financial health rating of FEMASYS INC (FEMY) is 0 / 10.
What is the earnings growth outlook for FEMASYS INC?
The Earnings per Share (EPS) of FEMASYS INC (FEMY) is expected to grow by 29.2% in the next year.